Nexus (BATS-CHIXE:NXUd) - Stock Price, News & Analysis

NXUd Stock Overview

Develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally.

About the company

NXUd fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	3/6
Past Performance	5/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 27.6% below our estimate of its fair value

Earnings are forecast to grow 15.8% per year

Earnings grew by 24.2% over the past year

Risk Analysis

Shares are highly illiquid

Nexus AG Competitors

Craneware

AIM:CRW

UK£772.5m

EMIS Group

AIM:EMIS

UK£1.2b

Instem

AIM:INS

UK£199.6m

CVS Group

AIM:CVSG

UK£743.0m

Price History & Performance

Summary of all time highs, changes and price drops for Nexus
Historical stock prices
Current Share Price	€60.70
52 Week High	€60.70
52 Week Low	€60.70
Beta	0.85
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	7.91%
5 Year Change	132.57%
Change since IPO	397.13%

Recent updates

Shareholder Returns

	NXUd	GB Healthcare Services	GB Market
7D	0%	-1.3%	-0.6%
1Y	n/a	39.6%	7.7%

Return vs Industry: Insufficient data to determine how NXUd performed against the UK Healthcare Services industry.

Return vs Market: Insufficient data to determine how NXUd performed against the UK Market.

Price Volatility

Is NXUd's price volatile compared to industry and market?
NXUd volatility
NXUd Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	6.7%
Market Average Movement	4.9%
10% most volatile stocks in GB Market	11.1%
10% least volatile stocks in GB Market	2.7%

Stable Share Price: NXUd has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine NXUd's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1989	1,930	Ingo Behrendt	www.nexus-ag.de

Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospital information systems and integrated diagnostic modules that cover various functional requirements of hospitals, psychiatric institutions, rehabilitation facilities, and diagnostic centers, as well as nursing homes.

Nexus AG Fundamentals Summary

How do Nexus's earnings and revenue compare to its market cap?
NXUd fundamental statistics
Market cap	€920.20m
Earnings (TTM)	€24.03m
Revenue (TTM)	€245.24m

38.3x

P/E Ratio

3.8x

P/S Ratio

Is NXUd overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NXUd income statement (TTM)
Revenue	€245.24m
Cost of Revenue	€175.49m
Gross Profit	€69.75m
Other Expenses	€45.72m
Earnings	€24.03m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 14, 2024

Earnings per share (EPS)	1.39
Gross Margin	28.44%
Net Profit Margin	9.80%
Debt/Equity Ratio	0%

How did NXUd perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

16%

Payout Ratio

Does NXUd pay a reliable dividends?

See NXUd dividend history and benchmarks

When do you need to buy NXUd by to receive an upcoming dividend?
Nexus dividend dates
Ex Dividend Date	May 16 2024
Dividend Pay Date	May 21 2024
Days until Ex dividend	7 days
Days until Dividend pay date	2 days